Intervacc’s developmental program for new vaccines against animal infectious diseases is summarised in the following table. Please, click on respective project name or indication to read more.
|INV274||Strep. suis infection||Piglets|
|INV412||Staph. aureus mastitis||Cow|
The successful clinical trials with vaccination against strangles using Strangvac®, based on fusions of recombinant proteins, demonstrates that our technology can be applied also for development of other vaccines.